Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.
The role of AQP4 in neuromyelitis optica: More answers, more questions.
Concomitant multiple sclerosis and another autoimmune disease: Does the clinical course change?
Acute disseminated encephalomyelitis secondary to serogroup B meningococcal vaccine.
Antiglutamatergic therapy for multiple sclerosis?
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells.
Central remyelination restores secure conduction.
Neurologic indications for therapeutic plasma exchange: 2011 update.
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.
Immune recognition of citrullinated epitopes.
TRAIL gene expression analysis in multiple sclerosis patients.
Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury.
Importance of early treatment initiation in the clinical course of multiple sclerosis.
Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
Qualitative perspectives on aquatic exercise initiation and satisfaction among persons with multiple sclerosis.
Paraparetic Guillain-Barré syndrome: Non-demyelinating reversible conduction failure restricted to the lower limbs.
Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism.
Chemical exchange saturation transfer of the cervical spinal cord at 7 T.
Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring.
Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
The devil is in the detail: Acute Guillain-Barré syndrome camouflaged as neurosarcoidosis in a critically ill patient admitted to an Intensive Care Unit.
Imaging of microglial activation in MS using PET: Research use and potential future clinical application.
Considerations in the development of generic disease therapies for multiple sclerosis.
Abnormal white matter microstructure and increased extracellular free-water in the cingulum bundle associated with delusions in chronic schizophrenia.
Safety of Striatal Infusion of siRNA in a Transgenic Huntington's Disease Mouse Model.
Pages
« first
‹ previous
…
734
735
736
737
738
739
740
741
742
…
next ›
last »